Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Nephrology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Nephrology Other
    Gender-Matched Organs Affect Failure, Success in Kidney Transplants - (DGNews)
    Controlling Bone Disease Improves Survival of Patients on Haemodialysis - (DGNews)
    Multitarget Immune Therapy Improves Outcomes of Severe Lupus Nephritis - (DGNews)
    Chronic Kidney Disease on the Rise, Yet Often Undiagnosed - (DGNews)
    Gastric Bypass Surgery Linked to Increased Risk of Kidney Stones - (DGNews)

    News archive

     Recent webcasts/CME - Nephrology Other
    • Treating Anemia in Chronic Kidney Disease: Can We Do Better?
    • What Can We Do When Patients Don't Respond to Treatment of Anemia in Chronic Kidney Disease?
    • Bridging Interdisciplinary and Resource Gaps in CKD-Anemia Management
      The Cardio-Renal Link: Preventing Cardiovascular Disease and Diabetes in Renal Transplant Recipients
      Use of Direct Thrombin Inhibitors for Treating Non-St-Segment Elevation Acute Coronary Syndromes in Special Patient Groups: Women, Diabetics, the Elderly, and Chronic Renal Insufficiency

      Webcasts/CME archive

       Recent cases - Nephrology Other
        A Clay-Shoveler's Fracture with Renal Transplantation and Osteoporosis: A Case Report
        Spontaneous Rupture of an Infected Renal Cyst and External Drainage Through a Lumbar Surgical Scar in a Male Patient with Cervical Spinal Cord Injury: A Case Report
        Scleroderma with Crescentic Glomerulonephritis: A Case Report
        Massive Hematuria Due to Congenital Renal Arteriovenous Malformation Mimicking a Renal Pelvis Tumor: A Case Report
        Dilation of Renal Artery Stenosis after Administration of Losartan

        Cases archive
          




        my personal edition > nephrology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Target Aldosterone Directly to Keep Protein Out of Urine: Presented at ASN

        By Roberta Friedman, PhD

        SAN DIEGO, CA -- November 17, 2003 -- Eplerenone, a selective blocker of aldosterone's receptor, can avert damage to endothelium and keep the kidneys working properly, according to study findings reported here November 14th at Renal Week 2003. Low doses of the drug are able to prevent patients with type 2 diabetes from developing proteinuria.

        The beneficial effect on renal function was achieved without harmful elevation of serum potassium, study investigator Murray Epstein, MD, said in his presentation. Dr. Epstein is a professor in the department of medicine at the University of Miami, Miami, Florida, United States.

        Prior work showed that 200 mg of the drug, recently approved in the U.S. for treating hypertension, prevented type 2 diabetics from developing proteinuria. The new findings are from a study of lower doses.

        "If one uses a lower dose, one can achieve the desired effect," Dr. Epstein said, "without paying the piper of hyperkalaemia."

        In the multicentre trial of 50 and 100 mg of the drug, the investigators randomised patients who had albuminuria, with a urinary albumen to creatinine ratio (UACR) greater than 50 mg/g. Patients took enalapril 20 mg and added amlodipine 2.5 mg if blood pressure was not controlled adequately by four weeks. Target blood pressure was 130 systolic and 80 diastolic. The dose of amlodipine could be doubled every two weeks to a maximum of 10 mg.

        "The need for amlodipine add-on was least in the 100 mg [eplerenone] arm, as we might have expected," Dr. Epstein said.

        A total of 270 patients participated. About 70 comprised each treatment group.

        At weeks 4, 8, and 12, UACR was lowered by 52% and 55% with the lower and higher doses of eplerenone, respectively. The difference was significant compared to the 13% decrease in UACR in patients who did not take that drug (P < .001).

        Thus, kidney function was boosted by the aldosterone blocker, "in both instances exceeding the monotherapy arm," said Dr. Epstein.

        Significant incidence of hyperkalaemia did not follow use of the aldosterone blocker, as assessed by either a greater than 5.5 mmol/L elevation on two consecutive occasions, or any elevation above 6.0 mmol/L. However, Dr. Epstein noted, hyperkalaemia occurred numerically more often with eplerenone: High serum potassium was documented in four of 86 patients taking the high dose and in two of 91 taking the low dose, compared to only one of the patients not taking the drug.

        Adverse effects, including impotence, gynecomastia or mastodynia, were not associated with the use of eplerenone.

        Dr. Epstein agreed with a comment from the audience -- that if one tries to prevent proteinuria by raising the dose of an ACE inhibitor, that would really risk hyperkalaemia.

        The study was funded by Pfizer, Inc.


        [Study title: The Selective Aldosterone Blocker Eplerenone Reduces Proteinuria Without Concomitant Hyperkalemia. Abstract F-FC026]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send